Distribution Agreement for New MAGPIX® Multiplexing System
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Merck Millipore acquired the original Luminex reagent partners – Linco and Upstate – for life science research in 2006. Since that acquisition, the company has strengthened its commitment to the xMAP platform through its growing line of MILLIPLEX® MAP kits, analysis software, and global sales force.
“New MAGPIX instrumentation, combined with our new MILLIPLEX MAG magnetic bead-based multi-analyte panels, analysis software, and biomarker services, provides researchers with a complete solution for rapid, accurate biomarker quantification,” said John Sweeney, Vice President, Life Sciences, at Merck Millipore.
Based on Luminex's xMAP Technology, the easy-to-use, low-maintenance MAGPIX instrument is compact – comparable in size to a desktop computer – making it attractive to smaller and lower-volume laboratories and institutions with limited resources and bench space. The instrument provides fast, accurate and easily reproducible results, helping to advance research across many disease states such as metabolic, inflammation, toxicity and neuroscience as well as applications in oncology and cell signaling.
MAGPIX Multiplexing System
“Merck Millipore has more than 10 years’ experience with the xMAP platform, and their global reach within key research and pharmaceutical laboratories will help bring this important advancement to institutions of all sizes for a variety of life science applications,” said Darin Leigh, Vice President, Commercial Operations, at Luminex.
“New MAGPIX instrumentation, combined with our new MILLIPLEX MAG magnetic bead-based multi-analyte panels, analysis software, and biomarker services, provides researchers with a complete solution for rapid, accurate biomarker quantification,” said John Sweeney, Vice President, Life Sciences, at Merck Millipore.
Based on Luminex's xMAP Technology, the easy-to-use, low-maintenance MAGPIX instrument is compact – comparable in size to a desktop computer – making it attractive to smaller and lower-volume laboratories and institutions with limited resources and bench space. The instrument provides fast, accurate and easily reproducible results, helping to advance research across many disease states such as metabolic, inflammation, toxicity and neuroscience as well as applications in oncology and cell signaling.
MAGPIX Multiplexing System
“Merck Millipore has more than 10 years’ experience with the xMAP platform, and their global reach within key research and pharmaceutical laboratories will help bring this important advancement to institutions of all sizes for a variety of life science applications,” said Darin Leigh, Vice President, Commercial Operations, at Luminex.
